Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000727433 | SCV000240960 | uncertain significance | not provided | 2014-03-18 | criteria provided, single submitter | clinical testing | p.Tyr631Cys (TAC>TGC): c.1892 A>G in exon 11 of the EFHC1 gene (NM_018100.3). The Y631C variant has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The Y631C variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is conserved in mammals but is not conserved in more distantly related species. In silico analysis predicts this variant is probably damaging to the protein structure/function. Therefore, based on the currently available information, it is unclear whether this variant is a pathogenic mutation or a rare benign variant. The variant is found in EPILEPSY panel(s). |
Eurofins Ntd Llc |
RCV000727433 | SCV000708516 | uncertain significance | not provided | 2018-03-16 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV000764652 | SCV000895773 | uncertain significance | Absence seizure; Juvenile myoclonic epilepsy | 2018-10-31 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000727433 | SCV004234679 | uncertain significance | not provided | 2023-11-10 | criteria provided, single submitter | clinical testing |